Tag: biotechnology
-
HHS Directs $100M for Covid-19 Venture Investments
The Department of Health and Human Services is allocating $100 million for venture investments in new technologies to prepare for future threats from Covid-19.
-
Company Gains Ultrasound-Linked Drug Capsule Technology
A company developing a drug delivery process with treatments activated by ultrasound received an option to license a key technology from its founders’ university labs.
-
Biotech, A.I. Companies Model Animal Studies/Clinical Trials
A discoverer of neuroscience therapies and a genomics data science company are developing machine learning models to predict clinical trial outcomes for ADHD drugs.
-
Trial Underway Testing Stem Cell Particles for Burns
A clinical trial has begun testing an experimental treatment for burns using off-the-shelf therapeutic particles derived from human bone marrow stem cells.
-
Regeneron Acquires Hearing Loss Biotech in $213M Deal
Regeneron Pharmaceuticals, a maker of synthetic biologic treatments, is acquiring Decibel Therapeutics, developer of gene therapies to treat hearing loss and balance disorders.
-
Companies to Assess Ovarian Health Biotech Drug
A women’s health biotechnology company is partnering with a Brazilian drug maker to evaluate a precision target and treatment for ovarian health disorders.
-
Trial Shows Vaccine Induces Chikungunya Immune Response
Initial findings from a large clinical trial testing a vaccine against the chikungunya virus show the vaccine generates protective antibodies in the vast majority of recipients.
-
Trial Advances of Dual-Action Cancer Immunotherapy
A clinical trial assessing a synthetic antibody to generate an immediate response and also generate a more durable treatment for solid tumor cancers, advanced to a mid-stage study.
-
Digital Chemistry Start-Up Gains $43M in Early Funds
A company, spun-off from academic labs that designs and produces new chemicals with artificial intelligence and robotics, is raising $42.7 million in its first venture funding round.
-
Companies Partner on Fast Production of Biologics in Plants
The developer of a biologic drug-making process with engineered plant crops is collaborating with a vertical farming company to create a network of biologics production facilities.